614 related articles for article (PubMed ID: 31377786)
1. Plasma galactose-deficient immunoglobulin A1 and loss of kidney function in patients with immunoglobulin A vasculitis nephritis.
Zhang X; Xie X; Shi S; Liu L; Lv J; Zhang H
Nephrol Dial Transplant; 2020 Dec; 35(12):2117-2123. PubMed ID: 31377786
[TBL] [Abstract][Full Text] [Related]
2. Serum levels of galactose-deficient IgA1 in Chinese children with IgA nephropathy, IgA vasculitis with nephritis, and IgA vasculitis.
Tang M; Zhang X; Li X; Lei L; Zhang H; Ling C; Ni J; Lv J; Liu X; Chen X
Clin Exp Nephrol; 2021 Jan; 25(1):37-43. PubMed ID: 32935202
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of serum and mesangial galactose-deficient IgA1 in patients with IgA nephropathy.
Wada Y; Matsumoto K; Suzuki T; Saito T; Kanazawa N; Tachibana S; Iseri K; Sugiyama M; Iyoda M; Shibata T
PLoS One; 2018; 13(11):e0206865. PubMed ID: 30388165
[TBL] [Abstract][Full Text] [Related]
4. A cross-sectional analysis of clinicopathologic similarities and differences between Henoch-Schönlein purpura nephritis and IgA nephropathy.
Sugiyama M; Wada Y; Kanazawa N; Tachibana S; Suzuki T; Matsumoto K; Iyoda M; Honda H; Shibata T
PLoS One; 2020; 15(4):e0232194. PubMed ID: 32324811
[TBL] [Abstract][Full Text] [Related]
5. Associations of ABO blood type and galactose-deficient immunoglobulin A1 with adverse outcomes in patients with IgA nephropathy.
Wang M; Lv J; Chen P; Yu G; Shi S; Liu L; Zhou X; Xu D; Zhao M; Zhang H
Nephrol Dial Transplant; 2021 Jan; 36(2):288-294. PubMed ID: 31603230
[TBL] [Abstract][Full Text] [Related]
6. Value of biomarkers for predicting immunoglobulin A vasculitis nephritis outcome in an adult prospective cohort.
Berthelot L; Jamin A; Viglietti D; Chemouny JM; Ayari H; Pierre M; Housset P; Sauvaget V; Hurtado-Nedelec M; Vrtovsnik F; Daugas E; ; Monteiro RC; Pillebout E;
Nephrol Dial Transplant; 2018 Sep; 33(9):1579-1590. PubMed ID: 29126311
[TBL] [Abstract][Full Text] [Related]
7. Zonulin, as a marker of intestinal permeability, is elevated in IgA nephropathy and IgA vasculitis with nephritis.
Li Q; Yuan X; Shi S; Liu L; Lv J; Zhu L; Zhang H
Clin Kidney J; 2023 Jan; 16(1):184-191. PubMed ID: 36726446
[TBL] [Abstract][Full Text] [Related]
8. Immunostaining of galactose-deficient IgA1 by KM55 is not specific for immunoglobulin A nephropathy.
Zhao L; Peng L; Yang D; Chen S; Lan Z; Zhu X; Yuan S; Chen G; Liu Y; Liu H
Clin Immunol; 2020 Aug; 217():108483. PubMed ID: 32479989
[TBL] [Abstract][Full Text] [Related]
9. Autoantibodies Specific for Galactose-Deficient IgA1 in IgA Vasculitis With Nephritis.
Suzuki H; Moldoveanu Z; Julian BA; Wyatt RJ; Novak J
Kidney Int Rep; 2019 Dec; 4(12):1717-1724. PubMed ID: 31844808
[TBL] [Abstract][Full Text] [Related]
10. Galactose-deficient IgA1 in skin and serum from patients with skin-limited and systemic IgA vasculitis.
Neufeld M; Molyneux K; Pappelbaum KI; Mayer-Hain S; von Hodenberg C; Ehrchen J; Barratt J; Suzuki Y; Sunderkötter C
J Am Acad Dermatol; 2019 Nov; 81(5):1078-1085. PubMed ID: 30902725
[TBL] [Abstract][Full Text] [Related]
11. Significance of serum galactose deficient IgA1 as a potential biomarker for IgA nephropathy: A case control study.
Bagchi S; Lingaiah R; Mani K; Barwad A; Singh G; Balooni V; Bhowmik D; Agarwal SK
PLoS One; 2019; 14(3):e0214256. PubMed ID: 30917188
[TBL] [Abstract][Full Text] [Related]
12. IgA nephropathy and IgA vasculitis with nephritis have a shared feature involving galactose-deficient IgA1-oriented pathogenesis.
Suzuki H; Yasutake J; Makita Y; Tanbo Y; Yamasaki K; Sofue T; Kano T; Suzuki Y
Kidney Int; 2018 Mar; 93(3):700-705. PubMed ID: 29329643
[TBL] [Abstract][Full Text] [Related]
13. The level of galactose-deficient IgA1 in the sera of patients with IgA nephropathy is associated with disease progression.
Zhao N; Hou P; Lv J; Moldoveanu Z; Li Y; Kiryluk K; Gharavi AG; Novak J; Zhang H
Kidney Int; 2012 Oct; 82(7):790-6. PubMed ID: 22673888
[TBL] [Abstract][Full Text] [Related]
14. Clinical Significance of Serum Galactose-Deficient IgA1 Level in Children with IgA Nephropathy.
Irabu H; Shimizu M; Kaneko S; Inoue N; Mizuta M; Ohta K; Yachie A
J Immunol Res; 2020; 2020():4284379. PubMed ID: 32537466
[TBL] [Abstract][Full Text] [Related]
15. Oxidative stress and galactose-deficient IgA1 as markers of progression in IgA nephropathy.
Camilla R; Suzuki H; Daprà V; Loiacono E; Peruzzi L; Amore A; Ghiggeri GM; Mazzucco G; Scolari F; Gharavi AG; Appel GB; Troyanov S; Novak J; Julian BA; Coppo R
Clin J Am Soc Nephrol; 2011 Aug; 6(8):1903-11. PubMed ID: 21784819
[TBL] [Abstract][Full Text] [Related]
16. Aberrant glycosylation of IgA1 is inherited in both pediatric IgA nephropathy and Henoch-Schönlein purpura nephritis.
Kiryluk K; Moldoveanu Z; Sanders JT; Eison TM; Suzuki H; Julian BA; Novak J; Gharavi AG; Wyatt RJ
Kidney Int; 2011 Jul; 80(1):79-87. PubMed ID: 21326171
[TBL] [Abstract][Full Text] [Related]
17. Novel lectin-independent approach to detect galactose-deficient IgA1 in IgA nephropathy.
Yasutake J; Suzuki Y; Suzuki H; Hiura N; Yanagawa H; Makita Y; Kaneko E; Tomino Y
Nephrol Dial Transplant; 2015 Aug; 30(8):1315-21. PubMed ID: 26109484
[TBL] [Abstract][Full Text] [Related]
18. Galactose-Deficient IgA1 as a Candidate Urinary Polypeptide Marker of IgA Nephropathy?
Suzuki H; Allegri L; Suzuki Y; Hall S; Moldoveanu Z; Wyatt RJ; Novak J; Julian BA
Dis Markers; 2016; 2016():7806438. PubMed ID: 27647947
[TBL] [Abstract][Full Text] [Related]
19. Glomerular galactose-deficient IgA1 expression analysis in pediatric patients with glomerular diseases.
Ishiko S; Horinouchi T; Fujimaru R; Shima Y; Kaito H; Tanaka R; Ishimori S; Kondo A; Nagai S; Aoto Y; Sakakibara N; Nagano C; Yamamura T; Yoshimura M; Nakanishi K; Fujimura J; Kamiyoshi N; Nagase H; Yoshikawa N; Iijima K; Nozu K
Sci Rep; 2020 Aug; 10(1):14026. PubMed ID: 32820208
[TBL] [Abstract][Full Text] [Related]
20. Serum levels of galactose-deficient IgA are elevated in patients with IgA nephropathy but do not correlate to disease activity or progression.
Elíasdóttir S; Khramova A; Saeed A; Guron G; Boi R; Mölne J; Ebefors K; Nyström J
BMC Nephrol; 2023 Jun; 24(1):160. PubMed ID: 37286948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
